Search research articles
Contact Us
Filters
Showing results (41-50 of 49) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 49 results.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 2, 2009
NCCN clinical practice guidelines in oncology: hepatobiliary cancers
Al B Benson, Thomas A Abrams, Edgar Ben-Josef, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 9, 2019
Guidelines Insights: Hepatobiliary Cancers, Version 2.2019
Al B Benson, Michael I D'Angelica, Daniel E Abbott, et al.
Journal for Immunotherapy of Cancer
|
January 25, 2024
Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders
Brandon M Huffman, Harshabad Singh, Lestat R Ali, et al.
Cancer Discovery
|
April 30, 2021
<i>FGFR2</i> Extracellular Domain In-Frame Deletions Are Therapeutically Targetable Genomic Alterations That Function as Oncogenic Drivers in Cholangiocarcinoma
James M Cleary, Srivatsan Raghavan, Qibiao Wu, et al.
Cancer Immunology Research
|
July 11, 2024
Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor
Paul E Oberstein, Andressa Dias Costa, Emily A Kawaler, et al.
JCO Precision Oncology
|
September 2, 2025
Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibition in Patients With Metastatic Pancreatic Cancer
Rishi Surana, Micaela Morgado, Ashwin Somasundaram, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 12, 2024
RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer
Harshabad Singh, Pranshu Sahgal, Kevin Kapner, et al.
JCO Precision Oncology
|
January 12, 2023
Programmatic Precision Oncology Decision Support for Patients With Gastrointestinal Cancer
Rachel B Keller, Tali Mazor, Lynette Sholl, et al.
Nature Medicine
|
January 26, 2023
Combined PD-1, BRAF and MEK inhibition in BRAF<sup>V600E</sup> colorectal cancer: a phase 2 trial
Jun Tian, Jonathan H Chen, Sherry X Chao, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 49) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 49 results.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 2, 2009
NCCN clinical practice guidelines in oncology: hepatobiliary cancers
Al B Benson, Thomas A Abrams, Edgar Ben-Josef, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 9, 2019
Guidelines Insights: Hepatobiliary Cancers, Version 2.2019
Al B Benson, Michael I D'Angelica, Daniel E Abbott, et al.
Journal for Immunotherapy of Cancer
|
January 25, 2024
Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders
Brandon M Huffman, Harshabad Singh, Lestat R Ali, et al.
Cancer Discovery
|
April 30, 2021
<i>FGFR2</i> Extracellular Domain In-Frame Deletions Are Therapeutically Targetable Genomic Alterations That Function as Oncogenic Drivers in Cholangiocarcinoma
James M Cleary, Srivatsan Raghavan, Qibiao Wu, et al.
Cancer Immunology Research
|
July 11, 2024
Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor
Paul E Oberstein, Andressa Dias Costa, Emily A Kawaler, et al.
JCO Precision Oncology
|
September 2, 2025
Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibition in Patients With Metastatic Pancreatic Cancer
Rishi Surana, Micaela Morgado, Ashwin Somasundaram, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 12, 2024
RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer
Harshabad Singh, Pranshu Sahgal, Kevin Kapner, et al.
JCO Precision Oncology
|
January 12, 2023
Programmatic Precision Oncology Decision Support for Patients With Gastrointestinal Cancer
Rachel B Keller, Tali Mazor, Lynette Sholl, et al.
Nature Medicine
|
January 26, 2023
Combined PD-1, BRAF and MEK inhibition in BRAF<sup>V600E</sup> colorectal cancer: a phase 2 trial
Jun Tian, Jonathan H Chen, Sherry X Chao, et al.
Page
of 5